Roche to suspend HIV research, seeing no advances
NEW YORK (Reuters) - Swiss pharmaceutical company Roche Holding AG will suspend its HIV research because none of its pending medicines represent significant improvement over existing drugs, a company spokeswoman said on Friday.
More: continued here
Leave a Reply
You must be logged in to post a comment.